5alpha-androst-16-en-3-one CAS: 18339-16-7

CAS NO: 18339-16-7
5alpha-androst-16-en-3-one
Chemical Name: 5ALPHA-ANDROST-16-EN-3-ONE
Molecular Formula: C19H28O
Formula Weight: 272.42
CAS No.: 18339-16-7
Description Review
Description

5alpha-androst-16-en-3-one, also known as dehydroepiandrosterone (DHEA), is a hormone produced by the adrenal gland and is essential for the production of other hormones such as testosterone and estrogen. Its chemical name is 5-Androsten-3beta-ol-17-one, its molecular formula is C19H28O2, and its molecular weight is 288.4 g/mol. The CAS number for 5alpha-androst-16-en-3-one is 18339-16-7.

Top Ten Keywords from Google and Synonyms:

  1. Hormone
  2. Adrenal gland
  3. Testosterone
  4. Estrogen
  5. Anti-aging
  6. Weight loss
  7. Memory enhancement
  8. Immune system
  9. Depression
  10. Libido

Health Benefits of 5alpha-androst-16-en-3-one: There are many health benefits associated with 5alpha-androst-16-en-3-one, including improved immune function, reduced risk of heart disease, increased energy levels, and enhanced memory function. It has also been suggested that this hormone may have anti-aging effects and could help to promote weight loss and improve overall well-being.

Potential Effects of 5alpha-androst-16-en-3-one: 5alpha-androst-16-en-3-one has been shown to produce a range of effects on human health and behavior. It plays a critical role in the production of other hormones, such as testosterone and estrogen, which can impact many aspects of physical and mental health. Some studies have suggested that supplementation with 5alpha-androst-16-en-3-one may help to improve immune function, enhance cognitive performance, and boost mood and libido.

Product Mechanism: The mechanism of action for 5alpha-androst-16-en-3-one is not yet fully understood, but it is believed to work by acting on certain target cells in the body and promoting the production of other hormones. This can help to maintain hormonal balance and support optimal bodily function.

Safety: Supplementation with 5alpha-androst-16-en-3-one should be approached with caution, as there is still much we do not know about its long-term effects on health. While it appears to be safe for most people when used in appropriate doses, there are potential risks associated with excessive consumption, particularly in people with underlying medical conditions.

Side Effects: Some common side effects associated with 5alpha-androst-16-en-3-one supplementation may include acne, hair loss, oily skin, and changes in menstrual cycles. Additionally, some people may experience mood changes or altered libido. If you experience any persistent or severe side effects, it is important to seek medical attention promptly.

Dosing Information: Dosing guidelines for 5alpha-androst-16-en-3-one will vary depending on the specific product being used and the individual's needs. In general, it is recommended that supplementation be initiated at low doses and gradually increased over time. It is important to follow all labeling instructions carefully and to consult with a healthcare provider before starting a new supplement regimen.

Conclusion: Overall, 5alpha-androst-16-en-3-one is a hormone with many potential health benefits, particularly in the areas of immune function, cognitive performance, and mood regulation. While more research is needed to fully understand its mechanisms of action and long-term effects, early findings suggest that it may be a promising tool in the fight against age-related decline and disease. If you are considering supplementation with 5alpha-androst-16-en-3-one, it is important to proceed with caution, seek guidance from a qualified healthcare provider, and closely monitor your body's response to treatment.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code